CAS: 14337-43-0; Ethyl 2-Chloro-2-(Hydroxyimino)Acetate

该化合物是一种该化合物是一种宝贵的中间媒介,特别是在准备异环化合物和功能化氧化氮方面. 氯和氢氧化锡组的存在使得有选择性的再活动,有利于在药品,农用化学品和特殊化学合成方面的应用. 其酯功能提高了有机溶剂的溶性,简化了反应系统的处理. 化合物的结构特征允许高效的衍生,使其在多步骤合成路径中发挥作用. 建议在非水性条件下适当储存以保持稳定. 适合需要精确的生态或核循环转化的受控反应.

结构式图片

相似化合物

30673-27-9 73188-60-0

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号31767-14-3 ethyl 2-(hydrox... | CAS号459-73-4 2-胺基乙酸乙酯 | CAS号31767-15-4 ethyl 2-(hydrox... | CAS号623-33-6 甘氨酸乙酯盐酸盐 | CAS号144-55-8 碳酸氢钠 | CAS号34428-17-6 ammonium 1-chlo... | CAS号626-35-7 硝基乙酸乙酯 | CAS号609-15-4 2-氯乙酰乙酸乙酯 | CAS号5408-04-8 2-(羟亚氨基)乙酰乙酸乙酯 | CAS号51983-62-1 ethyl oxycyanof... | CAS号109022-73-3 Ethyl 3a,4,6,6a... | CAS号33230-32-9 MFCD04969900 | CAS号3209-40-3 5-(氯甲基)异恶唑-3-羧酸乙酯 | CAS号3209-70-9 异噁唑-3-羧酸乙酯 | CAS号18417-40-8 diethyl 1,2,5-o... | CAS号37384-62-6 5-苯基-1,2,4-噁二唑-... | CAS号90005-77-9 4,5,6,7-四氢-1,2-... | CAS号190070-13-4 ethyl 4-((2-met... | CAS号25902-91-4 4(1H)-Pyrimidin... | CAS号81282-12-4 乙基-5-(4氯苯基)异恶唑-3-羧酸

合成工艺路线路线简述

    甘氨酸乙酯盐酸盐置于sodium Nitrite体系中,化学反应生成氯代肟基乙酸乙酯
    参考文献:亚硝基羰基杂diels-Alder环加合物向有用的异恶唑啉-碳环氨基的转化
    标题:亚硝基羰基杂diels-Alder环加合物向有用的异恶唑啉-碳环氨基的转化
    摘要:详细介绍了一种用于合成异恶唑啉-碳环核苷的有用前体的新方法,该方法从易于获得的n-苯甲酰基-2,3-氧杂氮杂硼烷-5-烯开始,并通过1,3-双极性环加成反应引入更多的极性和亲水性官能团由相应的羟肟基氯生成的或更方便地通过与硝基乙酸乙酯催化缩合生成的碳乙氧基甲腈氧化物.
    Doi:10.1016/j.Tet.2009.10.062

    海关参考信息

    专利信息


    专利号:WO-2022156692-A1
    优先权日:2021-01-22
    标 题 :Cyclic peptide viral protease inhibitor, preparation method therefor, and application thereof in antiviral drugs
    发明人:LI XINGZHOU; XU LEI; LI SONG; ZHONG WU; CAO RUIYUAN; XIAO JUNHAI; ZHOU XINBO; ZHENG ZHIBING; LI WEI; FAN SHIYONG; XIAO DIAN; WANG ZIHAO; XIE FEI
    权利人:ACAD OF MILITARY MEDICAL SCIENCES
    摘要:The present invention relates to the field of pharmaceutical chemicals, relates to a cyclic peptide compound as shown in formula M or a stereoisomer, a tautomer or a mixture of the compound, a pharmaceutically acceptable salt, a polymorph, a eutectic or a solvate of the compound, or a stable isotope derivative, a metabolite or a prodrug of the compound, and further relates to a method and an intermediate for synthesis of the cyclic peptide compound. The provided cyclic peptide compound has a strong inhibitory effect on 3CL protease of coronavirus and 3CL protease of picornaviridae, such as Enterovirus EV71 virus. By means of cell level activity testing, the provided cyclic peptide compound has a significant inhibitory effect on EV71 virus and coronavirus. Moreover, the cyclic peptide compound as shown in formula M can generate a virus inhibition effect on a cell level by inhibiting viral protease activity, and has a good application prospect in antiviral drugs.

    专利号:US-10858390-B2
    优先权日:2016-09-02
    标 题 :Use of excess carbodiimide for peptide synthesis at elevated temperatures
    发明人:COLLINS JONATHAN M; SINGH SANDEEP K
    权利人:CEM CORP
    摘要:An improved method of coupling amino acids into peptides or peptidomimetics is disclosed in which the activation and coupling are carried out in the same vessel, in the presence of a carbodiimide in an amount greater than 1 equivalent as compared to the amino acid, in the presence of an activator additive, and at a temperature greater than 30° C.

    专利号:US-3862225-A
    优先权日:1961-08-18
    标 题:D-ring substituted tetracyclines
    发明人:CONOVER LLOYD H; WOODWARD ROBERT B
    权利人:PFIZER
    摘要:The total synthesis of tetracycline-type antibiotics by a multistep process beginning with 3,4,10-trioxo-1,2,3,4,4a,9,9a, 10-octahydroanthracenes comprising: (1) an aldol condensation with a glyoxalic acid ester to give a 2-carboxymethylidene3,4,10-trioxo-1,2,3,4,4a,9,9a,10-octahydroanthracene ester; (2) Michael reaction of said ester with an amine to produce 3,4,10trioxo-1,2,3,4,4a,9,9a,10-octahydroanthracene-2-( Alpha amino)acetic acid ester; (3) conversion of the triketone to the corresponding 4,10-diketone by (a) selective reduction of the Michael reaction product to the corresponding 3-hydroxy compound, followed by conversion of the 3-hydroxy compound to the corresponding 3-formyloxy compound and removal of the 3-formyloxy group by treatment with zinc dust to give a 4,10-dioxo1,2,3,4,4a,9,9a,10-octahydroanthracene-2-( Alpha -amino)acetic acid ester; or (b) conversion of the hydrochloride salt of the Michael reaction product to a lactone by reaction with ptoluenesulfonic acid and treatment of the lactone with zinc dust formic acid; (4) conversion of the 4,10-diketo-1,2,3,4,4a,9,9a, 10-octahydroanthracene-2-( Alpha -amino)-acetic acid to a mixed anhydride; (5) followed by acylation of a malonic acid ester with the mixed anhydride; (6) cyclization of the acyl malonate derivative to a 12a-deoxytetracycline which is then hydroxylated to a tetracycline. The preparation of the 3,4,10-trioxo1,2,3,4,4a,9,9a,10-octahydroanthracenes from benzoyl halides by (a) Friedel-Crafts reaction of a benzoyl halide with a pyrocatechol ether, e.g., a di-(lower)alkyl ether, to produce a 3,4-di-(lower)alkoxybenzophenone; (b) conversion of the benzophenone by partial or complete reduction of the carbonyl group by chemical or catalytic methods to a 3,4-di-(lower)alkoxy diphenyl methanol or 3,4-di-(lower)alkoxy diphenyl methane; or to a 3,4-di-(lower)alkoxy diphenyl alkane via a Grignard reaction and reduction of the thus-produced alkanol; (c) oxidation of the 3,4-di-(lower)alkoxy diphenyl alkane, or the corresponding dihydroxy compound, to a dienedioic acid ester or dienedioic acid; (d) hydrogenation of the dienedioic acid compound to a benzyl adipic acid derivative; (e) cyclization of said compound to a 2-(2-carbalkoxyethyl)-4-tetralone by means of dehydrating or dehydrohalogenating agents; (f) cyclization of the 4-tetralone derivatives by condensation with a dialkyloxalate to give a 2carbalkoxy 3,4,10-trioxo-octahydroanthracene; and (g) removal of the 2-substituent by decarboxylation. The intermediates and final products are useful as bactericides and/or chelating agents.

    专利号:US-10393752-B2
    优先权日:2011-05-14
    标 题:Mass spectrometry-cleavable cross-linking agents
    发明人:RYCHNOVSKY SCOTT D; HUANG LAN
    权利人:UNIV CALIFORNIA
    摘要:Provided herein is synthesis of novel mass spectrometry-cleavable cross-linking agents. The novel mass spectrometry-cleavable cross-linking agents can be used in mass spectrometry, tandem mass spectrometry, and multi-stage tandem mass spectrometry to facilitate structural analysis of intra-protein interactions in proteins and inter-protein interactions in protein complexes. Also provided are methods of mapping intra-protein interactions in proteins and inter-protein interactions in protein complexes.

    专利号:US-10308677-B2
    优先权日:2014-12-19
    标题:Coupling method for peptide synthesis at elevated temperatures
    发明人:COLLINS JONATHAN M; SINGH SANDEEP KUMAR
    权利人:CEM CORP
    摘要:An improved method for coupling carboxylic acids and amines is disclosed that includes the steps of combining a hyper-acid sensitive linker connecting an amine and a resin, a carboxylic acid, a carbodiimide, an activator additive, and a base, and carrying out the activation and coupling at a temperature greater than 30° C.

    专利号:CA-2977720-A1
    优先权日:2016-09-02
    标题 :Use of excess carbodiimide for peptide synthesis at elevated temperatures
    济南大宇化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jinandayuchem.com
    企业联系电话:0531-87153728👤
    📞济南大宇化工有限公司 ⚠️参考联系方式
    联系人:徐经理
    电话:0531-87153728
    手机:13805401165
    传真:0531-87922099
    邮箱:xufeng192@126.com xufeng192@jinandayuchem.com
    通信地址: 济南市天桥区新材料交易产业园区西副楼
    邮编: 250022
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:济南市天桥区新材料交易产业园区西副楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    天津科创医药中间体技术生产力促进有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.scipharmacn.com
    企业联系电话:022-60116533👤
    📞天津科创医药中间体技术生产力促进有限公司 ⚠️参考联系方式
    联系人:王经理
    电话:022-60116533
    手机:13207668525
    传真:022-60979672
    邮箱:saleskc@scipharmacn.com
    通信地址: 天津市华苑产业园区(环外)海泰发展六道6号海泰绿色产业基地
    邮编: 300118
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:天津市华苑产业园区(环外)海泰发展六道6号海泰绿色产业基地
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海乔木化学科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.arborchemical.com
    企业联系电话:021-60451683👤
    📞上海乔木化学科技有限公司 ⚠️参考联系方式
    联系人:陈先生
    电话:021-60451683

    传真:021-60451682
    邮箱:sales@arborchemical.com
    通信地址: 上海市浦东新区曹路镇民冬路128号10幢3单元401室(恒鲁工业园)
    邮编: 201209
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市浦东新区曹路镇民冬路128号10幢3单元401室(恒鲁工业园)
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    郑州手性药物研究院有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.chiralspharm.cn
    企业联系电话:0371-55219111👤
    📞郑州手性药物研究院有限公司 ⚠️参考联系方式
    联系人:李经理
    电话:0371-55219111
    手机:13703711903
    传真:0371-55219111
    邮箱:chiraldrug01@zzcpi.org
    通信地址: 郑州市中原西路中原智谷2号楼研发中心15层
    邮编: 450121
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:郑州市中原西路中原智谷2号楼研发中心15层
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Clelia Dallanoce, Et Al. Synthesis Of Enantiopure Delta2-Isoxazoline Derivatives And Evaluation Of Their Affinity And Efficacy Profiles At Human Beta-Adrenergic Receptor Subtypes. Bioorg Med Chem. 2006 Jul 1;14(13):4393-401.

    合成参考文献


    摘要:Coldham, I.; Sheikh, N. S., Science of Synthesis: Applications of Domino Transformations in Organic Synthesis, (2015) 2, 65.
    参考文献:10.1007/bf02976363
    摘要:Lee HJ, Ko DH. A novel approach to the discovery of non-systemic anti-inflammatory steroids; antedrug. Arch Pharm Res. 1999 Jun;22(3):279–87. doi: 10.1007/bf02976363.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知